Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 150
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Genetics of synucleins in neurodegenerative diseases
José Brás,Elizabeth Gibbons,Rita Guerreiro
Acta Neuropathologica.2021;141(4)471
[DOI]
2a-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease
Sushil K Singh,Aloke Dutta,Gyan Modi
Future Medicinal Chemistry.2017;9(10)1039
[DOI]
3iPS cells in the study of PD molecular pathogenesis
Melanie M. Cobb,Abinaya Ravisankar,Gaia Skibinski,Steven Finkbeiner
Cell and Tissue Research.2018;373(1)61
[DOI]
4Upcoming diagnostic biomarkers with promising prospects in neurological disorders
Wasim Ahmad,Abuzer Ali,Amena Ali,Sana Khan,Saba Khan,Ibraheem Husain
Clinical and Experimental Pharmacology and Physiology.2020;47(3)347
[DOI]
5Looking Beyond the Core: The Role of Flanking Regions in the Aggregation of Amyloidogenic Peptides and Proteins
Sabine M. Ulamec,David J. Brockwell,Sheena E. Radford
Frontiers in Neuroscience.2020;14(3)347
[DOI]
6Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease
Manuel Menéndez-González,Huber Padilla-Zambrano,Cristina Tomás-Zapico,Benjamin García
Brain Sciences.2018;8(4)52
[DOI]
7Biomarkers of Major Depressive Disorder: Knowing is Half the Battle
Sahil Malik,Ravinder Singh,Govind Arora,Akriti Dangol,Sanjay Goyal
Clinical Psychopharmacology and Neuroscience.2021;19(1)12
[DOI]
8pH-Dependent Aggregation in Intrinsically Disordered Proteins Is Determined by Charge and Lipophilicity
Jaime Santos,Valentín Iglesias,Juan Santos-Suárez,Marco Mangiagalli,Stefania Brocca,Irantzu Pallarès,Salvador Ventura
Cells.2020;9(1)145
[DOI]
9Deciphering the anti-Parkinson’s activity of sulphated polysaccharides from Chlamydomonas reinhardtii on the a-Synuclein mutants A30P, A53T, E46K, E57K and E35K
Gitanjali P Panigrahi,Ankita R Rane,Sirisha L Vavilala,Sinjan Choudhary
The Journal of Biochemistry.2019;166(6)463
[DOI]
10Mass Spectrometric Analysis of Lewy Body-Enriched a-Synuclein in Parkinson’s Disease
Payel Bhattacharjee,Annika Öhrfelt,Tammaryn Lashley,Kaj Blennow,Ann Brinkmalm,Henrik Zetterberg
Journal of Proteome Research.2019;18(5)2109
[DOI]
11Prion Protein PRNP: A New Player in Innate Immunity? The Aß Connection
Richard Lathe,Jean-Luc Darlix
Journal of Alzheimer's Disease Reports.2017;1(1)263
[DOI]
12Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
S. L. Sison,S. C. Vermilyea,M. E. Emborg,A. D. Ebert
Current Neurology and Neuroscience Reports.2018;18(12)263
[DOI]
13Lipids at the Crossroad of a-Synuclein Function and Dysfunction: Biological and Pathological Implications
Natalia P. Alza,Pablo A. Iglesias González,Melisa A. Conde,Romina M. Uranga,Gabriela A. Salvador
Frontiers in Cellular Neuroscience.2019;13(12)263
[DOI]
14Linking Alpha-Synuclein to the Actin Cytoskeleton: Consequences to Neuronal Function
Marina I. Oliveira da Silva,Márcia A. Liz
Frontiers in Cell and Developmental Biology.2020;8(12)263
[DOI]
15Implications of alpha-synuclein nitration at tyrosine 39 in methamphetamine-induced neurotoxicity in vitro and in vivo
Hong-Hua Qiao,Lin-Nan Zhu,Yue Wang,Jia-Liang Hui,Wei-Bing Xie,Chao Liu,Ling Chen,Ping-Ming Qiu
Neural Regeneration Research.2019;14(2)319
[DOI]
16The Role of Aptamer Loaded Exosome Complexes in the Neurodegenerative Diseases
Simranjeet Singh Sekhon,Gna Ahn,Ga-Young Park,Dae-Young Park,Sang-Hee Lee,Ji-Young Ahn,Yang-Hoon Kim
Toxicology and Environmental Health Sciences.2019;11(2)85
[DOI]
17Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
Fauze Camargo Maluf,David Feder,Alzira Alves de Siqueira Carvalho
Parkinson's Disease.2019;2019(2)1
[DOI]
18Bone loss in C57BL/6J-OlaHsd mice, a substrain of C57BL/6J carrying mutated alpha-synuclein and multimerin-1 genes
Tamar Liron,Bitya Raphael,Sahar Hiram-Bab,Itai A. Bab,Yankel Gabet
Journal of Cellular Physiology.2018;233(1)371
[DOI]
19Familial Mutations May Switch Conformational Preferences in a-Synuclein Fibrils
Liang Xu,Buyong Ma,Ruth Nussinov,Damien Thompson
ACS Chemical Neuroscience.2017;8(4)837
[DOI]
20Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease
Isaac Deng,Frances Corrigan,Guangxi Zhai,Xin-Fu Zhou,Larisa Bobrovskaya
Brain, Behavior, & Immunity - Health.2020;4(4)100060
[DOI]
21Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease
Katarzyna Wize,Wojciech Kozubski,Jolanta Dorszewska
Brain, Behavior, & Immunity - Health.2018;4(4)100060
[DOI]
22Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko
RSC Advances.2020;10(1)215
[DOI]
23Finding a new purpose for old drugs
Evan Y. Snyder
Science.2017;357(6354)869
[DOI]
24Salt-bridge dynamics in intrinsically disordered proteins: A trade-off between electrostatic interactions and structural flexibility
Sankar Basu,Parbati Biswas
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2018;1866(5-6)624
[DOI]
25Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
Nashwa Amin,Xiaoning Tan,Qiannan Ren,Ning Zhu,Benson O.A. Botchway,Zhiying Hu,Marong Fang
Progress in Neuro-Psychopharmacology and Biological Psychiatry.2019;95(5-6)109674
[DOI]
26Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
Fatemeh N. Emamzadeh,Andrei Surguchov
Frontiers in Neuroscience.2018;12(5-6)109674
[DOI]
27Eye lens crystallin proteins inhibit the autocatalytic amyloid amplification nature of mature a-synuclein fibrils
Ricardo Gaspar,Tommy Garting,Anna Stradner,Peter Schuck
PLOS ONE.2020;15(6)e0235198
[DOI]
28Recent progress of drug nanoformulations targeting to brain
Abdur Rauf Khan,Xiaoye Yang,Manfei Fu,Guangxi Zhai
Journal of Controlled Release.2018;291(6)37
[DOI]
29Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson’s disease
Razvan-Marius Brazdis,Julian E Alecu,Daniel Marsch,Annika Dahms,Katrin Simmnacher,Sandra Lörentz,Anna Brendler,Yanni Schneider,Franz Marxreiter,Laurent Roybon,Beate Winner,Wei Xiang,Iryna Prots
Human Molecular Genetics.2020;29(7)1180
[DOI]
30Effect of rs3910105 in the Synuclein Gene on Dopamine Transporter Availability in Healthy Subjects
Youngduk Seo,Kyoungjune Pak,Hyun-Yeol Nam,Ju Won Seok,Myung Jun Lee,Eun-Joo Kim,Jae Meen Lee,Seong Jang Kim,In Joo Kim
Yonsei Medical Journal.2018;59(6)787
[DOI]
31Formation of Heterotypic Amyloids: a-Synuclein in Co-Aggregation
Karishma Bhasne,Samrat Mukhopadhyay
PROTEOMICS.2018;18(21-22)1800059
[DOI]
32CSF a-synuclein correlates with CSF neurogranin in late-life depression
Davide Bruno,Chelsea Reichert Plaska,Daniel P. A. Clark,Henrik Zetterberg,Kaj Blennow,Marcel M. Verbeek,Nunzio Pomara
International Journal of Neuroscience.2021;131(4)357
[DOI]
33Antibody Fragments as Tools for Elucidating Structure-Toxicity Relationships and for Diagnostic/Therapeutic Targeting of Neurotoxic Amyloid Oligomers
André L. B. Bitencourt,Raquel M. Campos,Erika N. Cline,William L. Klein,Adriano Sebollela
International Journal of Molecular Sciences.2020;21(23)8920
[DOI]
34Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
Carlo Scialò,Elena De Cecco,Paolo Manganotti,Giuseppe Legname
Viruses.2019;11(3)261
[DOI]
35Small molecule probes of protein aggregation
Lydia M Young,Alison E Ashcroft,Sheena E Radford
Current Opinion in Chemical Biology.2017;39(3)90
[DOI]
36Interaction between Parkin and a-Synuclein in PARK2-Mediated Parkinson’s Disease
Daniel Aghaie Madsen,Sissel Ida Schmidt,Morten Blaabjerg,Morten Meyer
Cells.2021;10(2)283
[DOI]
37Prion-like C-Terminal Domain of TDP-43 and a-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils
Shailendra Dhakal,Courtney E. Wyant,Hannah E. George,Sarah E. Morgan,Vijayaraghavan Rangachari
Journal of Molecular Biology.2021;433(10)166953
[DOI]
38Beyond Neuronal Microtubule Stabilization: MAP6 and CRMPS, Two Converging Stories
Camille Cuveillier,Benoit Boulan,Charlotte Ravanello,Eric Denarier,Jean-Christophe Deloulme,Sylvie Gory-Fauré,Christian Delphin,Christophe Bosc,Isabelle Arnal,Annie Andrieux
Frontiers in Molecular Neuroscience.2021;14(10)166953
[DOI]
39Role of Apolipoproteins and a-Synuclein in Parkinson’s Disease
Fatemeh Nouri Emamzadeh
Journal of Molecular Neuroscience.2017;62(3-4)344
[DOI]
40Comparing the Folds of Prions and Other Pathogenic Amyloids
José Flores-Fernández,Vineet Rathod,Holger Wille
Pathogens.2018;7(2)50
[DOI]
41Selective vulnerability in a-synucleinopathies
Javier Alegre-Abarrategui,Katherine R. Brimblecombe,Rosalind F. Roberts,Elisavet Velentza-Almpani,Bension S. Tilley,Nora Bengoa-Vergniory,Christos Proukakis
Acta Neuropathologica.2019;138(5)681
[DOI]
42Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
Luis D. Bernal-Conde,Rodrigo Ramos-Acevedo,Mario A. Reyes-Hernández,Andrea J. Balbuena-Olvera,Ishbelt D. Morales-Moreno,Rubén Argüero-Sánchez,Birgitt Schüle,Magdalena Guerra-Crespo
Frontiers in Neuroscience.2020;13(5)681
[DOI]
43Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides
Guru KrishnaKumar Viswanathan,Ashim Paul,Ehud Gazit,Daniel Segal
Frontiers in Cell and Developmental Biology.2019;7(5)681
[DOI]
446-Hydroxydopamine: a far from simple neurotoxin
Damir Varešlija,Keith F. Tipton,Gavin P. Davey,Andrew G. McDonald
Journal of Neural Transmission.2020;127(2)213
[DOI]
45Using NMR spectroscopy to investigate the role played by copper in prion diseases
Rawiah A. Alsiary,Mawadda Alghrably,Abdelhamid Saoudi,Suliman Al-Ghamdi,Lukasz Jaremko,Mariusz Jaremko,Abdul-Hamid Emwas
Neurological Sciences.2020;41(9)2389
[DOI]
46a-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients
Wojciech Paslawski,Justyna Zareba-Paslawska,Xiaoqun Zhang,Katharina Hölzl,Henrik Wadensten,Mohammadreza Shariatgorji,Shorena Janelidze,Oskar Hansson,Lars Forsgren,Per E. Andrén,Per Svenningsson
Proceedings of the National Academy of Sciences.2019;116(30)15226
[DOI]
47Anti-Parkinson's disease activity of phenolic acids from Eucommia ulmoides Oliver leaf extracts and their autophagy activation mechanism
Shanshan Zhang,Zhangping Yu,Jingyu Xia,Xuanming Zhang,Kechun Liu,Attila Sik,Meng Jin
Food & Function.2020;11(2)1425
[DOI]
48Physiological, molecular and genetic aspects of alpha-synuclein and its correlation with high alcohol consumption
Tania Yadira Martínez-Rodríguez,Mauricio Rey-Buitrago
Revista de la Facultad de Medicina.2019;67(3)315
[DOI]
49Identification of on- and off-pathway oligomers in amyloid fibril formation
Alexander J. Dear,Georg Meisl,Andela Šaric,Thomas C. T. Michaels,Magnus Kjaergaard,Sara Linse,Tuomas P. J. Knowles
Chemical Science.2020;11(24)6236
[DOI]
50Cellular Proteostasis in Neurodegeneration
Alberim Kurtishi,Benjamin Rosen,Ketan S. Patil,Guido W. Alves,Simon G. Møller
Molecular Neurobiology.2019;56(5)3676
[DOI]
51The role of posttranslational modifications of a-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors
Edward Pajarillo,Asha Rizor,Jayden Lee,Michael Aschner,Eunsook Lee
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2019;1865(8)1992
[DOI]
52The Antiaggregative and Antiamyloidogenic Properties of Nanoparticles: A Promising Tool for the Treatment and Diagnostics of Neurodegenerative Diseases
Monika Pichla,Grzegorz Bartosz,Izabela Sadowska-Bartosz,Marco Malaguti
Oxidative Medicine and Cellular Longevity.2020;2020(8)1
[DOI]
53Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease
David J. Marmion,Angela A. Rutkowski,Diptaman Chatterjee,Benjamin M. Hiller,Milton H. Werner,Erwan Bezard,Deniz Kirik,Thomas McCown,Steven J. Gray,Jeffrey H. Kordower
Neurobiology of Disease.2021;148(8)105184
[DOI]
54Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells
Wenbo Yu,Sheng Chen,Liang Cao,Jie Tang,Wei Xiao,Baoguo Xiao
Cell Biology and Toxicology.2018;34(4)291
[DOI]
55Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson’s disease: A Preliminary Study
Ashish Kumar Gupta,Komal Rani,Surabhi Swarnkar,Gaurav Khunger Kumar,Mohd Imran Khan,Ruchika Pokhriyal,Domada Ratna Kumar,Vinay Goyal,Manjari Tripathi,Rishab Gupta,Rakesh Kumar Chadda,Perumal Vanamail,Gururao Hariprasad
Journal of Central Nervous System Disease.2018;10(4)117957351880358
[DOI]
56Overexpression of a-Synuclein Reorganises Growth Factor Profile of Human Astrocytes
Büsra Sengül,Erdinç Dursun,Alexei Verkhratsky,Duygu Gezen-Ak
Molecular Neurobiology.2021;58(1)184
[DOI]
57Up-regulation of autophagy-related gene 5 (ATG5) protects dopaminergic neurons in a zebrafish model of Parkinson's disease
Zhan-ying Hu,Bo Chen,Jing-pu Zhang,Yuan-yuan Ma
Journal of Biological Chemistry.2017;292(44)18062
[DOI]
58Mitochondrial Protein Import Dysfunction in Pathogenesis of Neurodegenerative Diseases
Shweta Goyal,Rajnish Kumar Chaturvedi
Molecular Neurobiology.2021;58(4)1418
[DOI]
59The Cellular Environment Affects Monomeric a-Synuclein Structure
Amberley D. Stephens,Maria Zacharopoulou,Gabriele S. Kaminski Schierle
Trends in Biochemical Sciences.2019;44(5)453
[DOI]
60Alpha synuclein in hematopoiesis and immunity
Yu Pei,Robert W. Maitta
Heliyon.2019;5(10)e02590
[DOI]
61Reprint of “Ganglioside lipids accelerate a-synuclein amyloid formation”
Ricardo Gaspar,Jon Pallbo,Ulrich Weininger,Sara Linse,Emma Sparr
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2019;1867(5)508
[DOI]
62Remodeling microglia to a protective phenotype in Parkinson’s disease?
Ifeoluwa Oluleke Awogbindin,Ismail Ogunbayode Ishola,Marie-Kim St-Pierre,Micaël Carrier,Julie C. Savage,Thérèse Di Paolo,Marie-Ève Tremblay
Neuroscience Letters.2020;735(5)135164
[DOI]
63Unraveling the NaCl Concentration Effect on the First Stages of a-Synuclein Aggregation
Rafael Ramis,Joaquín Ortega-Castro,Bartolomé Vilanova,Miquel Adrover,Juan Frau
Biomacromolecules.2020;21(12)5200
[DOI]
64Intracellular Alpha-Synuclein and Immune Cell Function
Veselin Grozdanov,Karin M. Danzer
Frontiers in Cell and Developmental Biology.2020;8(12)5200
[DOI]
65Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson’s Disease and Related Diseases
Yan Sun,Chuang Guo,Lin Yuan,Wen Li,Zhan-You Wang,Feng Yue,Jia-Yi Li
Frontiers in Neuroscience.2020;14(12)5200
[DOI]
66In-vitro and in-silico investigation of protective mechanisms of crocin against E46K a-synuclein amyloid formation
Marzieh Ghasemi Tigan,Arezou Ghahghaei,Milad Lagzian
Molecular Biology Reports.2019;46(4)4279
[DOI]
67The contribution of Parkin, PINK1 and DJ-1 genes to selective neuronal degeneration in Parkinson's disease
Marc van der Vlag,Robbert Havekes,Pim R. A. Heckman
European Journal of Neuroscience.2020;52(4)3256
[DOI]
68Prion Efficiently Replicates in a-Synuclein Knockout Mice
Edoardo Bistaffa,Martina Rossi,Chiara Maria Giulia De Luca,Federico Cazzaniga,Olga Carletta,Ilaria Campagnani,Fabrizio Tagliavini,Giuseppe Legname,Giorgio Giaccone,Fabio Moda
Molecular Neurobiology.2019;56(11)7448
[DOI]
69Mechanical and thermodynamic properties of Aß42, Aß40, and a-synuclein fibrils: a coarse-grained method to complement experimental studies
Adolfo B Poma,Horacio V Guzman,Mai Suan Li,Panagiotis E Theodorakis
Beilstein Journal of Nanotechnology.2019;10(11)500
[DOI]
70Unravelling the effect ofN(e)-(carboxyethyl)lysine on the conformation, dynamics and aggregation propensity of a-synuclein
Laura Mariño,Rafael Ramis,Rodrigo Casasnovas,Joaquín Ortega-Castro,Bartolomé Vilanova,Juan Frau,Miquel Adrover
Chemical Science.2020;11(12)3332
[DOI]
71Early stages of Parkinson’s disease: aspects of the diagnosis and therapy
A. A. Pilipovich
Medical Council.2019;11(18)61
[DOI]
72Oxidative stress factors in Parkinson’s disease
Jolanta Dorszewska,Marta Kowalska,Michal Prendecki,Thomas Piekut,Joanna Kozlowska,Wojciech Kozubski
Neural Regeneration Research.2021;16(7)1383
[DOI]
73Ganglioside lipids accelerate a-synuclein amyloid formation
Ricardo Gaspar,Jon Pallbo,Ulrich Weininger,Sara Linse,Emma Sparr
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2018;1866(10)1062
[DOI]
74Modulation of a-synuclein fibrillation by plant metabolites, daidzein, fisetin and scopoletin under physiological conditions
Ankita R. Rane,Harshad Paithankar,Ramakrishna V. Hosur,Sinjan Choudhary
International Journal of Biological Macromolecules.2021;1866(10)1062
[DOI]
75DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers
Patricia S. Muñoz,Juan Segura-Aguilar
Neurotoxicity Research.2017;32(3)362
[DOI]
76Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology
Orkid Coskuner-Weber,Vladimir Uversky
International Journal of Molecular Sciences.2018;19(2)336
[DOI]
77Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology
Jaime Santos,Valentín Iglesias,Salvador Ventura
International Journal of Molecular Sciences.2020;169(2)43
[DOI]
78Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes
Ching-On Wong
International Journal of Molecular Sciences.2020;21(14)5149
[DOI]
79Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment
Jimena H. Martínez,Federico Fuentes,Virginia Vanasco,Silvia Alvarez,Agustina Alaimo,Adriana Cassina,Federico Coluccio Leskow,Francisco Velazquez
Archives of Biochemistry and Biophysics.2018;651(14)1
[DOI]
80Plasmaa-synuclein levels are increased in patients with obstructive sleep apnea syndrome
Hao-Lun Sun,Bin-Lu Sun,Dong-Wan Chen,Yang Chen,Wei-Wei Li,Man-Yu Xu,Ying-Ying Shen,Zhi-Qiang Xu,Yan-Jiang Wang,Xian-Le Bu
Annals of Clinical and Translational Neurology.2019;6(4)788
[DOI]
81MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
Hsiuying Wang
International Journal of Molecular Sciences.2021;22(6)2953
[DOI]
82Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?
Alexei A. Surguchev,Andrei Surguchov
Frontiers in Molecular Neuroscience.2017;10(6)2953
[DOI]
8314-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
Rachel Underwood,Mary Gannon,Aneesh Pathak,Navya Kapa,Sidhanth Chandra,Alyssa Klop,Talene A. Yacoubian
Acta Neuropathologica Communications.2021;9(1)2953
[DOI]
84A Coarse-Grained Molecular Dynamics Approach to the Study of the Intrinsically Disordered Protein a-Synuclein
Rafael Ramis,Joaquín Ortega-Castro,Rodrigo Casasnovas,Laura Mariño,Bartolomé Vilanova,Miquel Adrover,Juan Frau
Journal of Chemical Information and Modeling.2019;59(4)1458
[DOI]
85Alleviating toxic a-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson’s disease
Alysia Ross,Viktoria Xing,Ting Ting Wang,Samantha C. Bureau,Giovana A. Link,Teresa Fortin,Hui Zhang,Shawn Hayley,Hongyu Sun
Molecular Brain.2020;13(1)1458
[DOI]
86Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum
Thaiany Quevedo Melo,Sjef J. C. V. M. Copray,Merari F. R. Ferrari
Neurochemical Research.2018;43(12)2212
[DOI]
87Post-translational modifications of Parkinson's disease-related proteins: Phosphorylation, SUMOylation and Ubiquitination
Stella C. Junqueira,Eduarda G.Z. Centeno,Kevin A. Wilkinson,Helena Cimarosti
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2019;1865(8)2001
[DOI]
88Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
Maria Zella,Judith Metzdorf,Friederike Ostendorf,Fabian Maass,Siegfried Muhlack,Ralf Gold,Aiden Haghikia,Lars Tönges
Cells.2019;8(2)105
[DOI]
89Identifying the mechanisms of a-synuclein-mediated cytotoxicity in Parkinson’s disease: new insights from a bioinformatics-based approach
Sankha S Chakrabarti,Venkatadri S Sunder,Upinder Kaur,Sapna Bala,Priyanka Sharma,Manjari Kiran,Ravindra K Rawal,Sasanka Chakrabarti
Future Neurology.2020;15(3)FNL49
[DOI]
90Gut-Brain axis in Parkinson's disease etiology: The role of lipopolysaccharide
Dipita Bhattacharyya,Anirban Bhunia
Chemistry and Physics of Lipids.2021;235(3)105029
[DOI]
91Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects
Kyoungjune Pak,Seunghyeon Shin,So Jung Kim,Keunyoung Kim,Bum Soo Kim,Seong Jang Kim,In Joo Kim
Scientific Reports.2017;7(1)105029
[DOI]
92Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases
Minee L. Choi,Sonia Gandhi
The FEBS Journal.2018;285(19)3631
[DOI]
93Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders
Dharmendra Kumar Khatri,Amey Kadbhane,Monica Patel,Shweta Nene,Srividya Atmakuri,Saurabh Srivastava,Shashi Bala Singh
Current Research in Pharmacology and Drug Discovery.2021;2(19)100022
[DOI]
94a-Synuclein Trafficking in Parkinson’s Disease: Insights From Fly and Mouse Models
Jingjing Cheng,Qingqing Lu,Li Song,Margaret S. Ho
ASN Neuro.2018;10(19)175909141881258
[DOI]
95From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins
Cristóbal Marrero-Winkens,Charu Sankaran,Hermann Schätzl
Biomolecules.2020;10(9)1305
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal